APVOAptevo Therapeutics Inc.

Nasdaq aptevotherapeutics.com


$ 0.81 $ -0.02 (-2.42 %)    

Wednesday, 15-May-2024 13:10:41 EDT
QQQ $ 452.95 $ -0.47 (-0.1 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.93 $ 0.00 (0 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 0.808
$ 0.80
$ 0.00 x 0
$ 0.00 x 0
$ 0.80 - $ 0.81
$ 0.67 - $ 80.96
129,254
na
554,882
$ 2.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-05-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-13-2020 03-31-2020 10-Q
18 03-25-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-13-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-25-2016 06-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aptevo-therapeutics-q1-eps-995-beats-1284-estimate

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(9.95) per share which beat the analyst consensus estimate of $...

 nasdaq-jumps-250-points-crude-oil-down-1

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The D...

 why-aptevo-therapeutics-stock-is-cratering

Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereo...

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

 dow-dips-100-points-carmax-earnings-miss-views

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

 nasdaq-gains-over-50-points-us-producer-prices-increase-in-march

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the D...

 why-rallybio-shares-are-trading-higher-by-around-78-here-are-20-stocks-moving-premarket

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collabo...

 aptevo-therapeutics-announces-advancements-in-clinical-programs-and-one-preclinical-program

Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosi...

 why-is-immuno-oncology-focused-aptevo-therapeutics-stock-trading-higher-on-thursday

Interim results from the Phase 1 trial of ALG.APV-527 by Alligator Bioscience and Aptevo Therapeutics. Positive signs of clinic...

 alligator-bioscience-and-aptevo-therapeutics-announce-interim-data-of-dose-escalation-phase-of-algapv-527-phase-1-study-in-solid-tumor-cancers-expressing-tumor-antigen-5t4

Initial interim data show favorable drug exposure and confirm ALG.APV-527 biological activityEarly promising signs of clinical ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION